About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Effect of Curcumin on Lung Inflammation | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT01514266

Effect of Curcumin on Lung Inflammation

Chronic obstructive pulmonary disease (COPD) and lung cancer are leading causes of death and health care use. Diffuse airways inflammation is seen in COPD and is thought to be the reason for deteriora...

Lead sponsor: Baylor College of Medicine•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

Baylor College of Medicine

Collaborators

M.D. Anderson Cancer Center

Age

40 - 80 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Age equal or more than 45 with moderate COPD: FEV1/FVC ratio less than 70 percent; post bronchodilator FEV1 less than 50 percent
•20 pack year cigarette smoking
•Stable clinical course (symptoms/ medications) for 8 weeks
•Fixed address/Not planning to leave
•Being able to perform spirometry
•Able to understand and consent

Exclusion Criteria

•Other chronic respiratory diseases such as asthma, interstitial fibrosis, sarcoidosis
•Heart failure NYH III \& IV; symptomatic liver or renal failure
•Dementia or other neurocognitive deficit preventing completion of symptom diary
•Use of inhaled or systemic corticosteroids within 8 weeks of enrollment in the study

Related studies

RECRUITINGPhase 3

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

NCT07190209 · Chronic Obstructive Pulmonary Disease

RECRUITINGPhase 1/2

Feasibility of Semaglutide in Advanced Lung Disease

NCT05746039 · Obesity, Interstitial Lung Disease, and more

Study of Patient With Frequent Exacerbations in Moscow

NCT07307781 · Chronic Obstructive Pulmonary Disease (COPD)

RECRUITINGPhase 4

A Study to Investigate the Effect of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Compared With Placebo MDI on Heart and Lung Function in Participants With Chronic Obstructive Pulmonary Disease (COPD) and Hyperinflation

NCT07073950 · Chronic Obstructive Pulmonary Disease, Hyperinflation

Acute Effect of Different Frequency of Whole Body Vibration (WBV) on Healthy and Chronic Obstructive Pulmonary Disease (COPD)

NCT07509606 · Chronic Obstructive Pulmonary Disease (COPD), Whole Body Vibration

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 23, 2012Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment57

Start dateApr 2005

Last updatedJan 23, 2012

Condition

Chronic Obstructive Pulmonary Disease

Locations shown

VA Medical Center

Houston, Texas

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 23, 2012Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions